Purple Biotech Ltd
NASDAQ:PPBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Purple Biotech Ltd
NASDAQ:PPBT
|
IL |
|
Bollore SE
OTC:BOIVF
|
FR |
|
AT & S Austria Technologie & Systemtechnik AG
F:AUS
|
AT |
|
Amuse Inc
TSE:4301
|
JP |
Purple Biotech Ltd
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
